Literature DB >> 12767446

Comparison of the effects of pentaerythritol tetranitrate and nitroglycerin on endothelium-dependent vasorelaxation in male volunteers.

Tommaso Gori1, Abdul Al-Hesayen, Courtney Jolliffe, John D Parker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767446     DOI: 10.1016/s0002-9149(03)00342-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  11 in total

1.  A new class of organic nitrates: investigations on bioactivation, tolerance and cross-tolerance phenomena.

Authors:  S Schuhmacher; E Schulz; M Oelze; A König; C Roegler; K Lange; L Sydow; T Kawamoto; P Wenzel; T Münzel; J Lehmann; A Daiber
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

2.  Pentaerythritol tetranitrate improves angiotensin II-induced vascular dysfunction via induction of heme oxygenase-1.

Authors:  Swenja Schuhmacher; Philip Wenzel; Eberhard Schulz; Matthias Oelze; Christian Mang; Jens Kamuf; Tommaso Gori; Thomas Jansen; Maike Knorr; Susanne Karbach; Marcus Hortmann; Falk Mäthner; Aruni Bhatnagar; Ulrich Förstermann; Huige Li; Thomas Münzel; Andreas Daiber
Journal:  Hypertension       Date:  2010-02-15       Impact factor: 10.190

3.  Effects of pentaerythritol tetranitrate on endothelial function in coronary artery disease: results of the PENTA study.

Authors:  Boris Schnorbus; Robert Schiewe; Mir Abolfazl Ostad; Christoph Medler; Daniel Wachtlin; Philip Wenzel; Andreas Daiber; Thomas Münzel; Ascan Warnholtz
Journal:  Clin Res Cardiol       Date:  2009-12-02       Impact factor: 5.460

Review 4.  New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance.

Authors:  A Daiber; P Wenzel; M Oelze; T Münzel
Journal:  Clin Res Cardiol       Date:  2007-10-19       Impact factor: 5.460

5.  Sustained Formation of Nitroglycerin-Derived Nitric Oxide by Aldehyde Dehydrogenase-2 in Vascular Smooth Muscle without Added Reductants: Implications for the Development of Nitrate Tolerance.

Authors:  Marissa Opelt; Gerald Wölkart; Emrah Eroglu; Markus Waldeck-Weiermair; Roland Malli; Wolfgang F Graier; Alexander Kollau; John T Fassett; Astrid Schrammel; Bernd Mayer; Antonius C F Gorren
Journal:  Mol Pharmacol       Date:  2018-01-22       Impact factor: 4.436

Review 6.  Organic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate.

Authors:  Matthias Oelze; Swenja Schuhmacher; Andreas Daiber
Journal:  Exp Diabetes Res       Date:  2010-12-27

7.  Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy.

Authors:  Swenja Schuhmacher; Matthias Oelze; Franziska Bollmann; Hartmut Kleinert; Christian Otto; Tjebo Heeren; Sebastian Steven; Michael Hausding; Maike Knorr; Andrea Pautz; Kurt Reifenberg; Eberhard Schulz; Tommaso Gori; Philip Wenzel; Thomas Münzel; Andreas Daiber
Journal:  Diabetes       Date:  2011-08-15       Impact factor: 9.461

8.  Heme oxygenase-1 induction and organic nitrate therapy: beneficial effects on endothelial dysfunction, nitrate tolerance, and vascular oxidative stress.

Authors:  Andreas Daiber; Matthias Oelze; Philip Wenzel; Franziska Bollmann; Andrea Pautz; Hartmut Kleinert
Journal:  Int J Hypertens       Date:  2012-03-07       Impact factor: 2.420

9.  Direct Antioxidant Properties of Bilirubin and Biliverdin. Is there a Role for Biliverdin Reductase?

Authors:  Thomas Jansen; Andreas Daiber
Journal:  Front Pharmacol       Date:  2012-03-16       Impact factor: 5.810

10.  Pentaerythritol Tetranitrate In Vivo Treatment Improves Oxidative Stress and Vascular Dysfunction by Suppression of Endothelin-1 Signaling in Monocrotaline-Induced Pulmonary Hypertension.

Authors:  Sebastian Steven; Matthias Oelze; Moritz Brandt; Elisabeth Ullmann; Swenja Kröller-Schön; Tjebo Heeren; Lan P Tran; Steffen Daub; Mobin Dib; Dirk Stalleicken; Philip Wenzel; Thomas Münzel; Andreas Daiber
Journal:  Oxid Med Cell Longev       Date:  2017-02-28       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.